Guiding recombinant antivenom development by omics technologies

Andreas Hougaard Laustsen*

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

663 Downloads (Pure)


In this review, the different approaches that have been employed with the aim of developing novel antivenoms against animal envenomings are presented and discussed. Reported efforts have focused on the use of innovative immunization strategies, small molecule inhibitors against enzymatic toxins, endogenous animal proteins with toxin-neutralizing capabilities, and recombinant monoclonal antibodies. Harnessing either of these approaches, antivenom development may benefit from an in-depth understanding of venom compositions and the medical importance of individual venom toxins. Focus is thus also directed towards the different omics technologies (particularly venomics, antivenomics, and toxicovenomics) that are being used to uncover novel animal toxins, shed light on venom complexity, and provide directions for how to determine the medical relevance of individual toxins within whole venoms. Finally, techniques for assessing antivenom specificity and cross-reactivity are reviewed, with special focus on antivenomics and high-density peptide microarray technology.
Original languageEnglish
JournalNew Biotechnology
Pages (from-to)19-27
Publication statusPublished - 2018


  • Animal envenomings
  • Antivenomics
  • High-density peptide microarray technology
  • Omics technologies
  • Recombinant antivenom
  • Snakebite
  • Toxicovenomics
  • Venomics


Dive into the research topics of 'Guiding recombinant antivenom development by omics technologies'. Together they form a unique fingerprint.

Cite this